← Back to Search

Whole-Body Periodic Acceleration Therapy for Pain (Exer-Rest Trial)

Phase 3
Waitlist Available
Research Sponsored by Center for Translational Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Available for regular visits to the research site for the duration of the study
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks
Awards & highlights

Exer-Rest Trial Summary

This trial will test if a new treatment, whole body periodic acceleration, can help reduce aches and pains for patients.

Who is the study for?
This trial is for adults over 18 who have chronic pain, joint stiffness, or problems with walking and balance. They must be evaluated by a doctor for these issues, handle the motion of WBPA therapy, and commit to regular study visits. Pregnant individuals, those with unexplained leg pain, skin conditions, unstable spine injuries or intolerance to WBPA's motion are excluded.Check my eligibility
What is being tested?
The trial is testing Whole-Body Periodic Acceleration (WBPA) therapy to see if it can relieve symptoms like aches and pains. Participants will undergo this non-invasive treatment regularly while their symptoms are monitored through tests like qEEG and questionnaires.See study design
What are the potential side effects?
While specific side effects aren't listed for WBPA therapy in the provided information, common concerns may include discomfort from the motion or potential worsening of balance issues during treatment.

Exer-Rest Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can attend all required study visits.

Exer-Rest Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Self-report of pain
Secondary outcome measures
Quality of life

Find a Location

Who is running the clinical trial?

Center for Translational MedicineLead Sponsor

Media Library

Whole-Body Periodic Acceleration Therapy Clinical Trial Eligibility Overview. Trial Name: NCT01629810 — Phase 3
Pain Research Study Groups:
Pain Clinical Trial 2023: Whole-Body Periodic Acceleration Therapy Highlights & Side Effects. Trial Name: NCT01629810 — Phase 3
Whole-Body Periodic Acceleration Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT01629810 — Phase 3

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are subjects in this research project restricted to a certain age demographic?

"The age range for participants in this study is from 18 to 65 years old."

Answered by AI

Are there any eligibility requirements to join this research project?

"Eligible individuals for this study must be aged 18-65 and have a diagnosed balance disorder. Currently, the research team is looking to recruit 30 patients."

Answered by AI

Does this medication have the FDA's blessing?

"This particular Phase 3 trial has garnered enough evidence of safety to be given a 3."

Answered by AI
~2 spots leftby Mar 2025